|
|
| Nomenclature |
|
Symbol:
|
Tg(tetO-EGFR*delta19)11Hev
|
|
Name:
|
transgene insertion 11, Harold E Varmus
|
|
MGI ID: |
MGI:3690457 |
|
Synonyms: |
DEL11, EGFRdeltaL747-S752, TetO-EGFRdeltaL747-S752 |
|
Transgene:
|
Tg(tetO-EGFR*delta19)11Hev
Location:
unknown
|
|
Transgene
origin |
|
Strain of Origin:
|
(C57BL/6 x CBA)F2
|
|
Transgene
description |
|
Transgene
Type: | |
Transgenic (random, expressed) |
|
Mutation: | |
Insertion |
| |
|
Mutation details: A mutant human epidermal growth factor receptor cDNA lacking the segment encoded by exon 19 was cloned between the tetracycline-responsive element and an intron and polyadenylation signal from the mouse protamine 1 gene. Mice with this transgene that express the tetracycline transactivator (tTA) or reverse transactivator (rtTA) protein under control of a tissue-specific promoter can be induced to express the mutant EGFR in tissues or cell types of interest by administration/withdrawal of doxycycline. (J:109092)
|
|
Phenotypes
|
View phenotypes for all genotypes (concatenated display).
|
| Find Mice (IMSR) |
Mouse strains and cell lines available from the
International Mouse Strain Resource
(IMSR)
|
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available |
|
| References |
|
Original: |
J:109092
Politi K et al.,
"Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors."
Genes Dev 2006 Jun 1;20(11):1496-510
|
|
All: |
2 reference(s)
|
|
Analysis Tools
